1/23
01:34 pm
ewtx
Form 4 Edgewise Therapeutics, For: Jan 21 Filed by: Edris Badreddin
Low
Report
Form 4 Edgewise Therapeutics, For: Jan 21 Filed by: Edris Badreddin
1/21
04:05 pm
ewtx
Form 144 Edgewise Therapeutics, Filed by: Edris Badreddin
Low
Report
Form 144 Edgewise Therapeutics, Filed by: Edris Badreddin
1/20
04:14 pm
ewtx
Form 144 Edgewise Therapeutics, Filed by: Carruthers R Michael
Medium
Report
Form 144 Edgewise Therapeutics, Filed by: Carruthers R Michael
1/15
04:45 pm
ewtx
Form 144 Edgewise Therapeutics, Filed by: Carruthers R Michael
Low
Report
Form 144 Edgewise Therapeutics, Filed by: Carruthers R Michael
1/5
05:33 pm
ewtx
Form 4 Edgewise Therapeutics, For: Jan 02 Filed by: Fox Jonathan C
Low
Report
Form 4 Edgewise Therapeutics, For: Jan 02 Filed by: Fox Jonathan C
12/29
09:07 am
ewtx
Form 144 Edgewise Therapeutics, Filed by: Carruthers R Michael
Medium
Report
Form 144 Edgewise Therapeutics, Filed by: Carruthers R Michael
11/24
07:09 pm
ewtx
Form 4 Edgewise Therapeutics, For: Nov 19 Filed by: Martin Christopher Nathan
Medium
Report
Form 4 Edgewise Therapeutics, For: Nov 19 Filed by: Martin Christopher Nathan
11/24
07:06 pm
ewtx
Form 3 Edgewise Therapeutics, For: Nov 19 Filed by: Martin Christopher Nathan
Medium
Report
Form 3 Edgewise Therapeutics, For: Nov 19 Filed by: Martin Christopher Nathan
11/20
05:08 pm
ewtx
Form 8-K Edgewise Therapeutics, For: Nov 19
Low
Report
Form 8-K Edgewise Therapeutics, For: Nov 19
11/17
04:38 pm
ewtx
Form 144 Edgewise Therapeutics, Filed by: Carruthers R Michael
Low
Report
Form 144 Edgewise Therapeutics, Filed by: Carruthers R Michael
11/14
04:20 pm
ewtx
Form SCHEDULE 13G/A Edgewise Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A Edgewise Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
11/14
10:24 am
ewtx
Form SCHEDULE 13G/A Edgewise Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
Low
Report
Form SCHEDULE 13G/A Edgewise Therapeutics, Filed by: JANUS HENDERSON GROUP PLC
11/12
04:59 pm
ewtx
Form 144 Edgewise Therapeutics, Filed by: Russell Alan J
Medium
Report
Form 144 Edgewise Therapeutics, Filed by: Russell Alan J